DaVita (DVA) return on equity (ROE)

Return on equity · fiscal 2024
773.1%

DaVita (DVA) earned a return on equity of 773.1% in fiscal 2024 (the year ended December 31, 2024). That is 707.6 percentage points higher than the 65.5% of fiscal 2023. Figures as of 18 Nov 2026, 23:16 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2024
773.1%
Change on fiscal 2023
+707.6 pts
Highest on record
773.1%fiscal 2024
Lowest on record
4.3%fiscal 2018
Fiscal years on record
172008–2024

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

DaVita return on equity (ROE), in more detail

Across the 17 fiscal years on record (2008–2024), the highest was 773.1% in fiscal 2024 and the lowest 4.3% in fiscal 2018. The fiscal 2024 figure is higher than in every one of the 16 earlier fiscal years on record, whose median is 20.2%.

History · 17 fiscal years

Return on equity by fiscal year

DaVita return on equity (ROE), year by year

DaVita (DVA) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
2024773.1% 707.6 pts up
202365.5% 13.2 pts down
202278.7% 50.8 pts down
2021129.5% 73.6 pts up
202055.9% 17.9 pts up
201938.0% 33.7 pts up
20184.3% 9.8 pts down
201714.1% 4.8 pts down
201618.9% 13.4 pts up
20155.5% 8.4 pts down
201414.0% 0.3 pts down
201314.3% 0.0 pts
201214.2% 8.1 pts down
201122.3% 1.8 pts up
201020.5% 0.7 pts up
200919.8% 1.4 pts down
200821.2%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of DaVita and comparable companies
CompanyReturn on equityFiscal year
Fresenius Medical Care FMS7.4%2025
Kymera Therapeutics KYMR-19.7%2025
DaVita DVA773.1%2024

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on DVA

DaVita, figure by figure

DaVita (DVA) overview: price, valuation and scorecardAll health care companies by market value

DaVita return on equity (ROE): questions and answers

What is DaVita's return on equity?

DaVita (DVA) earned a return on equity of 773.1% in fiscal 2024 (the year ended December 31, 2024). That is 707.6 percentage points higher than the 65.5% of fiscal 2023.

Is DaVita's return on equity high or low compared with its own history?

The fiscal 2024 figure is higher than in every one of the 16 earlier fiscal years on record, whose median is 20.2%.

What are the highest and lowest return on equity figures on record for DaVita?

Across the 17 fiscal years on record (2008–2024), the highest was 773.1% in fiscal 2024 and the lowest 4.3% in fiscal 2018.

How is DaVita's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative. For DaVita it is on record here for 17 fiscal years, 2008 to 2024.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “DaVita (DVA) return on equity (ROE)”, data as of 18 November 2026. https://funkfolio.com/stock/DVA/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.